Imaging Skeletal Muscle Mitochondrial OXPHOS Activity In Acute Lymphoblastic Leukemia Survivors
NCT06819475 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60
Last updated 2026-05-18
Summary
The participants are being asked to take part in this trial, because the participant is a survivor of childhood cancer or agreed to be part of a volunteer group to understand the relation between cancer and cancer treatment and muscle weakness in survivors of Acute Lymphoblastic Leukemia (ALL). ALL is cancer of the blood and bone marrow.
Primary Objective
• To compare muscle mtOXPHOS activity and satellite cell content among ALL survivors and controls.
Secondary Objective
* To evaluate the association between muscle mtOXPHOS, muscle satellite cell content and physical performance in ALL survivors.
* To evaluate the association of muscle morphology and epigenetics with muscle mtOXPHOS in ALL survivors.
Conditions
- Childhood Cancer
- Muscle Weakness
Interventions
- DIAGNOSTIC_TEST
-
Magnetic Resonance Imaging
Non-invasive MRI will be used to measure the major muscle groups in the calf muscle mtOXPHOS in childhood survivors of Acute Lymphoblastic Leukemia (ALL) in SJLIFE cohort and community controls and measure how muscle mitochondria produce energy to function.
- DIAGNOSTIC_TEST
-
Magnetic Resonance Spectroscopy
Non-invasive MRS will be used to measure the major muscle groups in the calf muscle mtOXPHOS in childhood survivors of Acute Lymphoblastic Leukemia (ALL) in SJLIFE cohort and community controls and measure how muscle mitochondria produce energy to function.
- OTHER
-
Physical function assessment
As part of the SJLIFE visit in the Human Performance Lab, the participant's physical health will be assessed by testing muscle strength, physical function, and lean muscle mass.
- OTHER
-
Peripheral blood sample
Peripheral blood sample will be used to evaluate muscle morphology, mitochondrial health and epigenetic differences in the muscles of survivors and age/sex-matched community controls.
- OTHER
-
Skeletal muscle biopsy
Muscle biopsy will be used to evaluate muscle morphology, mitochondrial health and epigenetic differences in muscles of survivors and age/sex-matched community controls.
- DIAGNOSTIC_TEST
-
Muscle Ultrasound
Bilateral quadriceps and calf muscle ultrasound will be used to measure muscle volume by calculating the cross-sectional area using the Cavalieri method.
Sponsors & Collaborators
-
St. Jude Children's Research Hospital
lead OTHER
Principal Investigators
-
Puneet Bagga, PhD · St. Jude Children's Research Hospital
Study Design
- Allocation
- RANDOMIZED
- Purpose
- SCREENING
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2025-06-02
- Primary Completion
- 2027-03-31
- Completion
- 2028-01-31
Countries
- United States
Study Locations
More Related Trials
-
Assessment of Healing and Function After Reconstruction Surgery for Bone Sarcomas
NCT03442465 ·Status: RECRUITING
-
Combination Chemotherapy and Total-Body Irradiation Followed by Peripheral Stem Cell or Bone Marrow Transplantation in Treating Patients With Acute Lymphoblastic Leukemia
NCT00027547 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
UCMSC-Exo for Chemotherapy-induced Myelosuppression in Acute Myeloid Leukemia
NCT06245746 ·Status: RECRUITING ·Phase: PHASE1
-
Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma
NCT00004903 ·Status: UNKNOWN ·Phase: PHASE2
-
Combination Chemotherapy With or Without Donor Stem Cell Transplant in Treating Patients With Acute Lymphoblastic Leukemia
NCT00792948 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Efficacy and Tolerability of Zoledronic Acid With Radiotherapy in Pts With Advanced Osteolytic Bone Lesions
NCT00171964 ·Status: COMPLETED ·Phase: PHASE4
-
TMC (Topotecan, Cyclophosphamide and Melphalan) for Multiple Myeloma
NCT01039025 ·Status: COMPLETED ·Phase: PHASE2
-
Zoledronic Acid and Combination Chemotherapy in Treating Patients With Newly Diagnosed Metastatic Osteosarcoma
NCT00742924 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluation of the Spectra Optia® Mononuclear Cell Collection Procedure
NCT01292486 ·Status: COMPLETED ·Phase: NA
-
Combination Chemotherapy and Radiation Therapy Plus Bone Marrow Transplantation in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
NCT00002481 ·Status: UNKNOWN ·Phase: PHASE2
-
Chemotherapy and Rituximab With Peripheral Stem Cell Transplantation in Treating Patients With Mantle Cell Lymphoma
NCT00020943 ·Status: COMPLETED ·Phase: PHASE2
-
Trial Evaluating MGTA-456 in Patients With High-Risk Malignancy
NCT03674411 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Combination Chemotherapy and Bone Marrow and/or Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma
NCT00002521 ·Status: COMPLETED ·Phase: PHASE2
-
Short-term Fasting Prior to PD-1/PD-L1 Inhibitor Therapy for of Advanced or Metastatic Skin Malignancy
NCT04387084 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Chemotherapy Followed by Peripheral Stem Cell or Bone Marrow Transplant Compared With Chemotherapy Alone in Treating Patients With Small Cell Lung Cancer
NCT00011921 ·Status: UNKNOWN ·Phase: PHASE3
-
Combination Chemotherapy, Radiation Therapy, and Bone Marrow Transplantation in Treating Patients With Retinoblastoma
NCT00004006 ·Status: COMPLETED ·Phase: PHASE2
-
S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases
NCT00874211 ·Status: COMPLETED
-
Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Refractory Hodgkin's Disease or Non-Hodgkin's Lymphoma
NCT00002461 ·Status: COMPLETED ·Phase: PHASE2
-
Chemotherapy Plus Bone Marrow Transplantation in Treating Patients With Refractory Non-Hodgkin's Lymphoma, Hodgkin's Disease, or Multiple Myeloma
NCT00002552 ·Status: COMPLETED ·Phase: PHASE2
-
Testing a New Combination of Anti-cancer Drugs in Patients Newly Diagnosed With Ewing Sarcoma Who Have Cancer That Has Spread to Other Parts of the Body
NCT06820957 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2/PHASE3
-
Total-Body Irradiation, Cyclophosphamide, and Stem Cell Transplantation in Treating Patients With Hematologic Cancer
NCT00062140 ·Status: COMPLETED ·Phase: PHASE1
-
UARK 89-001 Phase II Study of Intensive "TOTAL THERAPY" For Untreated or Minimally Treated Patients With Multiple Myeloma
NCT00580372 ·Status: COMPLETED ·Phase: PHASE2
-
Early Allogeneic Hematopoietic Cell Transplantation in Treating Patients With Relapsed or Refractory High-Grade Myeloid Neoplasms
NCT02756572 ·Status: COMPLETED ·Phase: PHASE2
-
Total-Body Irradiation and Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney Cancer
NCT00027820 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
High-Dose Melphalan, Total-Body Irradiation, and Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma in First Relapse
NCT00002630 ·Status: COMPLETED ·Phase: PHASE2